Antimicrobials cost as much to develop as other drugs, but don’t earn the same returns. Congress could give drugmakers a boost, but time is running out.Thanks for listening to WIRED. Check back in tomorrow to hear more stories from WIRED.com.
Learn about your ad choices:
dovetail.prx.org/ad-choices
